T. Rowe Price Associates’s Aemetis AMTX Stock Holding History
Bought
Maintained
Sold
Other funds holding AMTX
T. Rowe Price Associates's AMTX Position: Q2 2026 in Review
T. Rowe Price Associates increased its Aemetis (AMTX) stake by 255% in Q2 2026, buying an estimated $210K and bringing the position to 119,806 shares worth $197K. The position accounts for ﹤0.01% of the portfolio, ranked #3013.
T. Rowe Price Associates first reported a position in AMTX in Q3 2021 and has held it in 20 quarters since. The position peaked at $481K in Q1 2022. 88 funds tracked by Wall St. Rank hold AMTX as of Q2 2026.
- T. Rowe Price Associates held 119,806 shares of Aemetis worth $197K as of Q2 2026.
- T. Rowe Price Associates bought 86,043 Aemetis shares in Q2 2026, an estimated $210K.
- Aemetis made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #3013 holding.
- T. Rowe Price Associates first reported a position in Aemetis in Q3 2021 and has held it in 20 quarters since.
- T. Rowe Price Associates's Aemetis position peaked at $481K in Q1 2022.
- 88 funds tracked by Wall St. Rank held Aemetis as of Q2 2026.
Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.